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Introduction
A ‘gender gap’ exists in Cystic Fibrosis (CF). Females
acquire earlier microbial infections; have worse lung
function and poorer survival rates [1]. The sex-hormone
estrogen (estradiol, E2) has recently been highlighted as a
key molecule responsible for the CF gender dichotomy
[2]. Pseudomonas aeruginosa which colonises the CF
lung and dominates at end stage disease undergoes
mucoid conversion in response to E2 [2,3]. The aim of
this project was to study other roles of E2 in host and
pathogen responses by investigating its effects on the
growth rate of Ps. aeruginosa and the expression of cata-
lase and superoxide dismutase (SOD) in CF bronchial
epithelial cells.
Methods
Growth rate of Ps. aeruginosa (PA01) in the presence or
absence of E2 was measured by recording optical density
(OD 600nm) at different time points and by calculating
cfu/ml. Measurements of catalase and SOD gene expres-
sion in E2-treated CFBE410- airway epithelial cells were
carried out using real time qRT-PCR. Results were ana-
lysed using Graphpad PRISM 5.0.
Results
E2 had no effect on the growth of Ps. aeruginosa when
compared to control. The expression of catalase mRNA in
CFBE410- cells in response to E2 was not altered however,
there was two-fold increase in SOD gene expression in
response to 10 nM E2, 24hr (p= 0.0057).
Conclusion
Estradiol has no effect on the growth of Ps. aeruginosa
in vitro. In CF bronchial epithelial cells although catalase
gene expression remains unchanged, E2 increases SOD
expression, potentially increasing hydrogen peroxide
levels and contributing to Ps. aeruginosa mucoid
conversion.
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